The Federal Government has signed two letters of agreement with Siemens Healthineers, its Nigerian partner Tanit Medical Engineering and Abbott Laboratories GmbH, to enhance healthcare access and capacity in Nigeria.
The National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain, PVAC, Dr. Abdu Mukhtar, who represented the Nigerian government, signed the letters, with the Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, in attendance.
A statement signed by the Deputy Director of Information and Public Relations, Alaba Balogun, says these partnerships will boost the assembly of ultrasound systems, improve medical training for Nigerian professionals, enhance the self-sufficiency of the national healthcare system, and guarantee access to high-quality locally produced diagnostic solutions.
According to the statement, Professor Pate lauds Dr. Mukhtar and his team for their determination to attract investors to Nigeria and explains the Executive Order that offers incentives for those investing in the health sector.
According to the statement
Dr. Mukhtar also explains that the agreement reflects PVAC’s commitment to decreasing reliance on imports and enhancing future access to medical devices.
“This MoU embodies our shared vision for advancing healthcare, enhancing access, improving outcomes, and unlocking the potential of Nigeria’s healthcare value chain,” he adds.
It adds that the Vice President and Head of Public Sector Engagement for Siemens Healthineers in the Middle East and Africa, Dr. Kevin Massoudi, reaffirms Siemens’ dedication to advancing diagnostic services in Nigeria, while also recognizing the country’s pivotal role in health innovation throughout the continent.
Also Vice President of EMEA & Global Accounts at Abbott Laboratories GmbH, Dr. Rabah El Menshawy, remarks that the Memorandum of Understanding, MoU, applauds the leadership of President Bola Ahmed Tinubu, whose ambitious vision lays the foundation for a brighter future in Nigeria’s healthcare sector.
“Our collaboration is focused on supporting Nigeria’s goal of ending HIV infections by 2030—an objective that aligns with our company’s mission to promote health equity and empower individuals to lead healthier, fuller lives.”
Menshawy further states that the initiative will represents an opportunity to contribute to Nigeria’s economy as he believes that local production of rapid diagnostic tests will create employment opportunities and build local capacity through training and knowledge transfer.
